Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Apr 15, 2022; 14(4): 897-919
Published online Apr 15, 2022. doi: 10.4251/wjgo.v14.i4.897
Figure 2
Figure 2 Survival curve analyses for patients and receiver operating characteristic curves of inflammatory indices. A: Survival curves of all patients; B-D: Survival curves of patients with the expansive growth type (INFa), the intermediate type (INFb), and the infiltrative growth type (INFc); E-H: Receiver operating characteristic curve of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and systemic immune-inflammation index in all patients, INFa group, INFb group, and INFc group. INFa: The expansive growth type; INFb: The intermediate type; INFc: The infiltrative growth type; ROC: Receiver operating characteristic; NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-lymphocyte ratio; SII: Systemic immune-inflammation index.